<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="./datadict_v2.xsl"?><data_table id="pht004630.v2" study_id="phs000892.v2" participant_set="2" date_created="Tue Sep 29 12:14:49 2015"><description>Participant ID, race, ethnicity, gender, medical history of malignancy among participants, pubes with plasma, anatomic site of tumor specimen, method of blood collection, blood collection time, normal samples, age of tissue procurement, tumor sample 1, 2, 3, 4, 5, number of tumor samples, anesthesia, Case Report Form, tumor histology, tumor grade, residual tumor, tumor stage, tumor surgical devascularized time, pathological diagnosis, anatomic position of tumor specimen, chemotherapy, hormonal therapy, neo-adjuvant treatment, and radiation therapy of participants with ovarian cancer and involved in the "Clinical Proteomic Tumor Analysis Consortium (CPTAC) Proteogenomic Confirmatory Study of Breast, Colon, Lung, and Ovarian Tumors" project.</description><unique_key phv="00225289" version="2">Participant_ID</unique_key><unique_key phv="00225290" version="2">CRF_Name</unique_key><variable id="phv00225289.v2"><name>Participant_ID</name><description>De-Identified subject (Participant) ID, from the pre-printed labels that are part of the procurement package provided by the BCR.</description><type>string</type></variable><variable id="phv00225290.v2"><name>CRF_Name</name><description>Information collected on Case Report Form (CRF) at.  [Submission; Baseline; 1 year follow-up; 5 year follow-up]</description><type>string</type></variable><variable id="phv00225291.v2"><name>Participant_Procurement_Age</name><description>Provide the participant age in months at the time of tissue procurement.</description><type>number</type><unit>Months</unit></variable><variable id="phv00225292.v2"><name>Participant_Gender</name><description>Participant gender using the defined categories. [Male; Female; Unknown; Unspecified]</description><type>string</type></variable><variable id="phv00225293.v2"><name>Participant_Race</name><description>Participant race using the defined categories. Options = American Indian or Alaska Native; Asian; White; Black or African American;  Native Hawaiian or other Pacific Islander; Not Evaluated; Unknown (Could not be determined or unsure).</description><type>string</type></variable><variable id="phv00225294.v2"><name>Participant_Ethnicity</name><description>Ethnicity using the defined categories. [Not Hispanic or Latino; Hispanic or Latino; Not Evaluated; Unknown]</description><type>string</type></variable><variable id="phv00225295.v2"><name>Participant_Jewish_Heritage</name><description>Name for Jewish heritage categories for a patient/participant on a clinical trial. If the patient is known to be Jewish, but it is not known whether they are Ashkenazi or Sephardic, choose Jewish, NOS. [Ashkenazi; Sephardic; Jewish, NOS; Unknown; Not Jewish]</description><type>string</type></variable><variable id="phv00225296.v2"><name>Participant_History_Malignancy</name><description>Indicate whether the patient was, at any time in their life, diagnosed with a malignancy prior to the diagnosis of the specimen submitted for CPTAC.  If the patient has had a prior malignancy, an additional form (the Other Malignancy Form) must be completed for each prior malignancy. (If this question cannot be answered because the answer is unknown, the case will be excluded from CPTAC. If the patient has a history of multiple diagnoses of basal or squamous cell skin cancer, complete an OMF for the first diagnosis for each of these types.) [No; Yes, Only Non-melanomatous Skin Cancer Within the Last Year; Yes, Only In Situ Cervical Cancer Within the Last Year;  Yes, Only Non-melanomatous Skin Cancer and In Situ Cervical Cancer Within the Last Year; Yes, History of Other Cancer Greater Than One Year Ago]</description><type>string</type></variable><variable id="phv00225297.v2"><name>Participant_History_Chemotherapy</name><description>Did participant ever received systematic chemotherapy for any previous cancer. [No; Yes]</description><type>string</type></variable><variable id="phv00225300.v2"><name>Participant_History_Neo-adjuvant_Treatment</name><description>Did participant received therapy for this cancer prior to sample procurement of the tumor submitted for CPTAC.  If the participant did receive treatment for this cancer prior to procurement, the TSS should contact the BCR for further instructions.(Note: Systemic treatment and certain localized therapies (those administered to the same site as the CPTAC submitted tissue) given prior to procurement of the sample submitted for CPTAC are exclusionary.) [Yes; No]</description><type>string</type></variable><variable id="phv00225298.v2"><name>Participant_History_Radiation_Therapy</name><description>Indicate whether the patient every received radiation therapy involving the abdomen or pelvis. [No; Yes]</description><type>string</type></variable><variable id="phv00225299.v2"><name>Participant_History_Hormonal_Therapy</name><description>Indicate whether the patient received hormonal therapy for cancer within the last five years. [No; Yes]</description><type>string</type></variable><variable id="phv00225301.v2"><name>Aliquots_Plasma</name><description>Number of tubes of plasma obtained from the participant.</description><type>number</type></variable><variable id="phv00225302.v2"><name>Blood_Collection_Time</name><description>The 24-hr clock time on the day of when the CPTAC blood sample(s) was/were collected from the participant.</description><type>number</type><unit>(HR(24):MN)</unit></variable><variable id="phv00225303.v2"><name>Blood_Collection_Method</name><description>Method for obtaining the blood sample. [Venipuncture (Vacutainer Apparatus); Venipuncture (Syringe); IV Catheter]</description><type>string</type></variable><variable id="phv00225304.v2"><name>Anesthesia_Time</name><description>Time when anesthesia was administered to the participant.</description><type>number</type><unit>(HR(24):MN)</unit></variable><variable id="phv00225305.v2"><name>Tumor_Surgical_Devascularized_Time</name><description>The 24-hr clock time when the tumor was de-vascularized.</description><type>number</type><unit>(HR(24):MN)</unit></variable><variable id="phv00225306.v2"><name>Tumor_Sample_Number</name><description>Specify the number of segments of the tumor that were removed and saved to the CPTAC-provided cryomolds.</description><type>number</type><unit>Number of segments</unit></variable><variable id="phv00225307.v2"><name>Tumor_Sample_1_Weight</name><description>Weight of tumor segment in mg.</description><type>number</type><unit>mg</unit></variable><variable id="phv00225308.v2"><name>Tumor_Sample_1_LN2_Time</name><description>The 24-hour clock time when tumor segment 1 was immersed in LN2 vapor.</description><type>number</type><unit>(HR(24):MN)</unit></variable><variable id="phv00226966.v2"><name>Tumor_Sample_1_Ischemia_Time</name><description>Calculated ischemia time. The difference between time of immersion in LN2 and Surgical de-vascularization time.</description><type>number</type><unit>Minutes</unit></variable><variable id="phv00225309.v2"><name>Tumor_Sample_2_Weight</name><description>Weight of tumor segment in mg.</description><type>"</type><unit>number</unit><value>mg</value></variable><variable id="phv00225310.v2"><name>Tumor_Sample_2_LN2_Time</name><description>The 24-hour clock time when the tumor segment 2 was immersed in LN2 vapor.</description><type>number</type><unit>(HR(24):MN)</unit></variable><variable id="phv00226967.v2"><name>Tumor_Sample_2_Ischemia_Time</name><description>Calculated ischemia time. The difference between time of immersion in LN2 and Surgical de-vascularization time.</description><type>number</type><unit>Minutes</unit></variable><variable id="phv00225311.v2"><name>Tumor_Sample_3_Weight</name><description>Weight of tumor segment in mg.</description><type>number</type><unit>mg</unit></variable><variable id="phv00225312.v2"><name>Tumor_Sample_3_LN2_Time</name><description>The 24-hour clock time when the tumor sample or portion  was immersed in LN2 vapor.</description><type>number</type><unit>(HR(24):MN)</unit></variable><variable id="phv00226968.v2"><name>Tumor_Sample_3_Ischemia_Time</name><description>Calculated ischemia time. The difference between time of immersion in LN2 and Surgical de-vascularization time.</description><type>number</type><unit>Minutes</unit></variable><variable id="phv00225313.v2"><name>Tumor_Sample_4_Weight</name><description>Weight of tumor segment in mg.</description><type>number</type><unit>mg</unit></variable><variable id="phv00225314.v2"><name>Tumor_Sample_4_LN2_Time</name><description>The 24-hour clock time when the tumor sample or portion  was immersed in LN2 vapor.</description><type>number</type><unit>(HR(24):MN)</unit></variable><variable id="phv00226969.v2"><name>Tumor_Sample_4_Ischemia_Time</name><description>Calculated ischemia time. The difference between time of immersion in LN2 and surgical de-vascularization time.</description><type>number</type><unit>Minutes</unit></variable><variable id="phv00225315.v2"><name>Tumor_Sample_5_Weight</name><description>Weight of tumor segment in mg.</description><type>number</type><unit>mg</unit></variable><variable id="phv00225316.v2"><name>Tumor_Sample_5_LN2_Time</name><description>The 24-hour clock time when the tumor sample or portion  was immersed in LN2 vapor.</description><type>number</type><unit>(HR(24):MN)</unit></variable><variable id="phv00226970.v2"><name>Tumor_Sample_5_Ischemia_Time</name><description>Calculated ischemia time. The difference between time of immersion in LN2 and Surgical de-vascularization time.</description><type>number</type><unit>Minutes</unit></variable><variable id="phv00225317.v2"><name>Normal_Sample_Number</name><description>Specify the number of normal segments that were removed and saved to the CPTAC-provided cryomolds.</description><type>"</type><unit>number</unit><value>Number of normal segments</value></variable><variable id="phv00225318.v2"><name>Normal_Sample_1_Surgical_Devascularized_Time</name><description>The 24-hr clock time when normal tissue sample was de-vascularized.</description><type>_</type><unit>"</unit><value>(HR(24):MN)</value><value>number</value></variable><variable id="phv00225319.v2"><name>Normal_Sample_1_Weight</name><description>Weight of normal segment in mg.</description><type>number</type><unit>mg</unit></variable><variable id="phv00225320.v2"><name>Normal_Sample_1_LN2_Time</name><description>The 24-hour clock time when the normal segment  was immersed in LN2 vapor.</description><type>number</type><unit>(HR(24):MN)</unit></variable><variable id="phv00226971.v2"><name>Normal_Sample_1_Ischemia_Time</name><description>Calculated ischemia time. The difference between time of immersion in LN2 and surgical de-vascularization time.</description><type>number</type><unit>Minutes</unit></variable><variable id="phv00225321.v2"><name>Normal_Sample_2_Surgical_Devascularized_Time</name><description>The 24-hr clock time when normal tissue sample was de-vascularized.</description><type>number</type><unit>(HR(24):MN)</unit></variable><variable id="phv00225322.v2"><name>Normal_Sample_2_Weight</name><description>Weight of normal segment in mg.</description><type>number</type><unit>mg</unit></variable><variable id="phv00225323.v2"><name>Normal_Sample_2_LN2_Time</name><description>The 24-hour clock time when the normal segment  was immersed in LN2 vapor.</description><type>number</type><unit>(HR(24):MN)</unit></variable><variable id="phv00226972.v2"><name>Normal_Sample_2_Ischemia_Time</name><description>Calculated ischemia time. The difference between time of immersion in LN2 and surgical de-vascularization time.</description><type>number</type><unit>Minutes</unit></variable><variable id="phv00225324.v2"><name>Normal_Sample_3_Surgical_Devascularized_Time</name><description>The 24-hr clock time when normal tissue sample was de-vascularized.</description><type>number</type><unit>(HR(24):MN)</unit></variable><variable id="phv00225325.v2"><name>Normal_Sample_3_Weight</name><description>Weight of normal segment in mg.</description><type>number</type><unit>mg</unit></variable><variable id="phv00225326.v2"><name>Normal_Sample_3_LN2_Time</name><description>The 24-hour clock time when the normal segment  was immersed in LN2 vapor.</description><type>number</type><unit>(HR(24):MN)</unit></variable><variable id="phv00226973.v2"><name>Normal_Sample_3_Ischemia_Time</name><description>Calculated ischemia time. The difference between time of immersion in LN2 and surgical de-vascularization time.</description><type>number</type><unit>Minutes</unit></variable><variable id="phv00225327.v2"><name>Normal_Sample_4_Surgical_Devascularized_Time</name><description>The 24-hr clock time when normal tissue sample was de-vascularized.</description><type>number</type><unit>(HR(24):MN)</unit></variable><variable id="phv00225328.v2"><name>Normal_Sample_4_Weight</name><description>Weight of normal segment in mg.</description><type>number</type><unit>mg</unit></variable><variable id="phv00225329.v2"><name>Normal_Sample_4_LN2_Time</name><description>The 24-hour clock time when the normal segment  was immersed in LN2 vapor.</description><type>number</type><unit>(HR(24):MN)</unit></variable><variable id="phv00226974.v2"><name>Normal_Sample_4_Ischemia_Time</name><description>Calculated ischemia time. The difference between time of immersion in LN2 and surgical de-vascularization time.</description><type>number</type><unit>Minutes</unit></variable><variable id="phv00225330.v2"><name>Normal_Sample_5_Surgical_Devascularized_Time</name><description>The 24-hr clock time when normal tissue sample was de-vascularized.</description><type>number</type><unit>(HR(24):MN)</unit></variable><variable id="phv00225331.v2"><name>Normal_Sample_5_Weight</name><description>Weight of normal segment in mg.</description><type>number</type><unit>mg</unit></variable><variable id="phv00225332.v2"><name>Normal_Sample_5_LN2_Time</name><description>The 24-hour clock time when the normal segment  was immersed in LN2 vapor.</description><type>number</type><unit>(HR(24):MN)</unit></variable><variable id="phv00226975.v2"><name>Normal_Sample_5_Ischemia_Time</name><description>Calculated ischemia time. The difference between time of immersion in LN2 and surgical de-vascularization time.</description><type>number</type><unit>Minutes</unit></variable><variable id="phv00225333.v2"><name>Origin_Site_Disease</name><description>Using the patient pathology report, select the site of origin of disease. [ovary; peritoneum; peritoneum; fallopian tube]</description><type>string</type></variable><variable id="phv00225334.v2"><name>Anatomic_Site_Tumor</name><description>Select the anatomic site of the tumor specimen submitted to CPTAC. [omentum; peritoneum; ovary; fallopian tube; pelvic mass]</description><type>string</type></variable><variable id="phv00225335.v2"><name>Anatomic_Lateral_Position_Tumor</name><description>Select the anatomic lateral position (side) for the tumor specimen used for CPTAC. [Right; Left; Bilateral;  Not applicable]</description><type>string</type></variable><variable id="phv00225336.v2"><name>Histological_Subtype</name><description>Using the patient pathology/laboratory report, select the histology and/or subtype of the tumor submitted for CPTAC. (Note: All other subtypes not listed are excluded from this study.) [Serous adenocarcinoma]</description><type>string</type></variable><variable id="phv00225337.v2"><name>Method_of_Pathologic_Diagnosis</name><description>Indicate the procedure utilized to procure the tissue which was used for the original diagnosis of the tissue submitted to CPTAC. [Excisional Biopsy; Incisional Biopsy; Tumor resection]</description><type>string</type></variable><variable id="phv00225338.v2"><name>Tumor_Stage_Ovary_FIGO</name><description>Assignment of FIGO stage used to select and evaluate therapy, estimate prognosis and calculate end results. (I: Tumor limited to ovaries (one or both), IA: Tumor limited to one ovary: no ascites present containing malignant cells. No tumor on the external surface; capsule intact., IB: Tumor limited to both ovaries; no ascites present containing malignant cells. No tumor on the external surfaces; capsules intact. , IC: Tumor either stage Ia or Ib, but with tumor on surface of one or both ovaries, or with capsule ruptured, or with ascites present containing malignant cells, or with positive peritoneal washings., II: Tumor involving one or both ovaries with pelvic extension. , IIA: Extension and/or metastases to the uterus and/or tubes. , IIB: Extension to other pelvic tissues., IIC: Tumor either stage IIa or IIb, but with tumor on surface of one or both ovaries, or with capsule(s) ruptured, or with ascites present containing malignant cells, or with positive peritoneal washings., III: Tumor involves one or both ovaries with histologically confirmed peritoneal implants outside the pelvis and/or positive regional lymph nodes. Superficial liver metastases equals stage III. Tumor is limited to the true pelvis, but with histologically proven malignant extension to small bowel or omentum., IIIA: Tumor grossly limited to the true pelvis, with negative nodes, but with histologically confirmed microscopic seeding of abdominal peritoneal surfaces, or histologic proven extension to small bowel or mesentery., IIIB: Tumor of one or both ovaries with histologically confirmed implants, peritoneal metastasis of abdominal peritoneal surfaces, none exceeding 2 cm in diameter; nodes are negative., IIIC: Peritoneal metastasis beyond the pelvis &gt;2 cm in diameter and/or positive regional lymph nodes., IV: Growth involving one or both ovaries with distant metastases. If pleural effusion is present, there must be positive cytology to allot a case to stage IV. Parenchymal liver metastasis equals stage IV. ) [I; IA; IB; IC; II; IIA; IIB; IIC; III; IIIA; IIIB; IIIC; IV]</description><type>string</type></variable><variable id="phv00225339.v2"><name>Tumor_Grade</name><description>Using the patient pathology/laboratory report, select the tumor grade of the tumor submitted to CPTAC. [G1; G2; G3; GB; GX]</description><type>string</type></variable><variable id="phv00225340.v2"><name>Tumor_Residual_Disease_Max_Diameter</name><description>Category to represent the maximal diameter in millimeters of the largest remaining nodule of ovarian carcinoma.</description><type>string</type><unit>mm</unit></variable></data_table>
